Related Experiment Video

Updated: Jun 14, 2025

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.0K

First immunogenicity and safety data on live chikungunya vaccine in an endemic area

David O Freedman1, Annika Beate Wilder-Smith2, Annelies Wilder-Smith3

  • 1University of Alabama at Birmingham, Birmingham, AL, USA.

The Lancet. Infectious Diseases
|September 7, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

8.7K
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.0K
Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

8.7K
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.2K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K
Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K

Articles linked to this work by shared authors, journal, and citation graph.

Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Optimizing dengue vaccination strategies.

PLoS medicine·2026

Country-level perspectives and priorities to guide the development of Invasive non-Typhoidal Salmonella (iNTS) vaccines: Insights from seven countries.

PLoS neglected tropical diseases·2026

The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges ahead.

Vaccine·2026

Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement.

Annals of internal medicine·2025

Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines.

Nature communications·2025

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.

The Lancet. Infectious diseases·2026

Evaluating the impact of antiviral post-exposure prophylaxis for health-care workers during orthoebolavirus outbreaks: a modelling study.

The Lancet. Infectious diseases·2026

Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.

The Lancet. Infectious diseases·2026

Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.

The Lancet. Infectious diseases·2026

Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trial.

The Lancet. Infectious diseases·2026

Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study.

The Lancet. Infectious diseases·2026

Dengue virus rNS3pro immunization is associated with the expansion of regulatory-like T-cell phenotypes in BALB/c mice.

Acta tropica·2026

Abelmoschus manihot (L.) leaf flavonoids (AMLF) restore cyclophosphamide-induced immunosuppression in mice via gut microbiota and serum metabolomics modulation.

Food & function·2026

Albumin and the kidney, a friend or foe.

Current opinion in critical care·2026

CLEC-1 promotes early IFN response in cDC1s and favors immune dysregulation during sepsis in mice.

iScience·2026

Claudin-12 sustains urothelial barrier defense against uropathogenic E. coli via calcium-dependent immunomodulation.

iScience·2026

MiR-122 regulates liver tolerance.

JHEP reports : innovation in hepatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us